BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 31626843)

  • 1. Dichotomous role of TGF-β controls inducible regulatory T-cell fate in allergic airway disease through Smad3 and TGF-β-activated kinase 1.
    Joetham A; Schedel M; Ning F; Wang M; Takeda K; Gelfand EW
    J Allergy Clin Immunol; 2020 Mar; 145(3):933-946.e4. PubMed ID: 31626843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inducible and naturally occurring regulatory T cells enhance lung allergic responses through divergent transcriptional pathways.
    Joetham A; Schedel M; O'Connor BP; Kim S; Takeda K; Abbott J; Gelfand EW
    J Allergy Clin Immunol; 2017 Apr; 139(4):1331-1342. PubMed ID: 27542981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro Conversion into CD4+CD25+Foxp3+ Induced Regulatory T Cells Is Reduced in Atopic Dermatitis Patients.
    García EM; Galicia-Carreón J; Novak N
    Int Arch Allergy Immunol; 2020; 181(5):353-356. PubMed ID: 32160611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of CDK2 promotes inducible regulatory T-cell differentiation through TGFβ-Smad3 signaling pathway.
    Gu H; Ding L; Xiong SD; Gao XM; Zheng B
    Cell Immunol; 2014 Jul; 290(1):138-44. PubMed ID: 24978614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRAF6 inhibits Th17 differentiation and TGF-beta-mediated suppression of IL-2.
    Cejas PJ; Walsh MC; Pearce EL; Han D; Harms GM; Artis D; Turka LA; Choi Y
    Blood; 2010 Jun; 115(23):4750-7. PubMed ID: 20351308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galectin-9-CD44 interaction enhances stability and function of adaptive regulatory T cells.
    Wu C; Thalhamer T; Franca RF; Xiao S; Wang C; Hotta C; Zhu C; Hirashima M; Anderson AC; Kuchroo VK
    Immunity; 2014 Aug; 41(2):270-82. PubMed ID: 25065622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smad3 differentially regulates the induction of regulatory and inflammatory T cell differentiation.
    Martinez GJ; Zhang Z; Chung Y; Reynolds JM; Lin X; Jetten AM; Feng XH; Dong C
    J Biol Chem; 2009 Dec; 284(51):35283-6. PubMed ID: 19887374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of SMAD and non-SMAD signals in the development of Th17 and regulatory T cells.
    Lu L; Wang J; Zhang F; Chai Y; Brand D; Wang X; Horwitz DA; Shi W; Zheng SG
    J Immunol; 2010 Apr; 184(8):4295-306. PubMed ID: 20304828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-12 inhibits the TGF-β-dependent T cell developmental programs and skews the TGF-β-induced differentiation into a Th1-like direction.
    Prochazkova J; Pokorna K; Holan V
    Immunobiology; 2012 Jan; 217(1):74-82. PubMed ID: 21903294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dichotomous response to transforming growth factor β after T cell receptor activation by naive CD4+ T cells from DBA/1 mice: enhanced retinoic acid receptor-related orphan nuclear receptor γt expression yet reduced FoxP3 expression.
    Morita Y; Ismail DM; Elkon KB; Chu CQ
    Arthritis Rheum; 2011 Jan; 63(1):118-26. PubMed ID: 20862680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. All-trans retinoic acid promotes TGF-β-induced Tregs via histone modification but not DNA demethylation on Foxp3 gene locus.
    Lu L; Ma J; Li Z; Lan Q; Chen M; Liu Y; Xia Z; Wang J; Han Y; Shi W; Quesniaux V; Ryffel B; Brand D; Li B; Liu Z; Zheng SG
    PLoS One; 2011; 6(9):e24590. PubMed ID: 21931768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell-intrinsic STING signaling promotes regulatory T cell induction and immunosuppression by upregulating FOXP3 transcription in cervical cancer.
    Ni H; Zhang H; Li L; Huang H; Guo H; Zhang L; Li C; Xu JX; Nie CP; Li K; Zhang X; Xia X; Li J
    J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36126994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinoic acid increases Foxp3+ regulatory T cells and inhibits development of Th17 cells by enhancing TGF-beta-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor expression.
    Xiao S; Jin H; Korn T; Liu SM; Oukka M; Lim B; Kuchroo VK
    J Immunol; 2008 Aug; 181(4):2277-84. PubMed ID: 18684916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-2 controls the stability of Foxp3 expression in TGF-beta-induced Foxp3+ T cells in vivo.
    Chen Q; Kim YC; Laurence A; Punkosdy GA; Shevach EM
    J Immunol; 2011 Jun; 186(11):6329-37. PubMed ID: 21525380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TNF-α impairs differentiation and function of TGF-β-induced Treg cells in autoimmune diseases through Akt and Smad3 signaling pathway.
    Zhang Q; Cui F; Fang L; Hong J; Zheng B; Zhang JZ
    J Mol Cell Biol; 2013 Apr; 5(2):85-98. PubMed ID: 23243069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A kinetic and dynamic analysis of Foxp3 induced in T cells by TGF-beta.
    Selvaraj RK; Geiger TL
    J Immunol; 2007 Jul; 179(2):11 p following 1390. PubMed ID: 17695668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activin a promotes the TGF-beta-induced conversion of CD4+CD25- T cells into Foxp3+ induced regulatory T cells.
    Huber S; Stahl FR; Schrader J; Lüth S; Presser K; Carambia A; Flavell RA; Werner S; Blessing M; Herkel J; Schramm C
    J Immunol; 2009 Apr; 182(8):4633-40. PubMed ID: 19342638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Helminth secretions induce de novo T cell Foxp3 expression and regulatory function through the TGF-β pathway.
    Grainger JR; Smith KA; Hewitson JP; McSorley HJ; Harcus Y; Filbey KJ; Finney CA; Greenwood EJ; Knox DP; Wilson MS; Belkaid Y; Rudensky AY; Maizels RM
    J Exp Med; 2010 Oct; 207(11):2331-41. PubMed ID: 20876311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concomitant suppression of T
    Na H; Lim H; Choi G; Kim BK; Kim SH; Chang YS; Nurieva R; Dong C; Chang SH; Chung Y
    J Allergy Clin Immunol; 2018 Jun; 141(6):2061-2073.e5. PubMed ID: 28943467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smad2 and Smad3 are redundantly essential for the TGF-beta-mediated regulation of regulatory T plasticity and Th1 development.
    Takimoto T; Wakabayashi Y; Sekiya T; Inoue N; Morita R; Ichiyama K; Takahashi R; Asakawa M; Muto G; Mori T; Hasegawa E; Saika S; Hara T; Nomura M; Yoshimura A
    J Immunol; 2010 Jul; 185(2):842-55. PubMed ID: 20548029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.